Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6194087 | Urologic Oncology: Seminars and Original Investigations | 2014 | 6 Pages |
Abstract
To our knowledge, this is the first description of PAK6 and PSMB4 expression in the diagnostic specimens of men with PC who were treated with RT. If confirmed by further studies, increased expression of these genes could be used to identify patients at a high risk of developing local failure following high-dose RT, thus better tailoring treatments for the individual patient.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Almudena Ph.D., Manuel Ph.D., Santiago M.D., Carmen Ph.D., Consuelo M.D., Magdalena M.D., Ramón M.D., Maria Jesus Ph.D., Feliciano Ph.D., Luis Miguel M.D., Olwen M.D.,